EUVIMEDEUVIMED entdecken
Multizentrische StudieValidierungsstudieOpen Access · CC BY 4.0

Artificial Intelligence‐Assisted Urine Cytology for Noninvasive Detection of Muscle‐Invasive Urothelial Carcinoma: A Multi‐Center Diagnostic Study with Prospective Validation

Runnan Shen, Fan Jiang, Xiaowei Huang, Guibin Hong, Yun Luo, Huan Wan, Ye Xie, Mengyi Zhu, Yun Wang, Bohao Liu, Ping Qin, Yahui Wang und 8 weitere

Advanced Science · 2025-10 · 12 (39)

DOI: 10.1002/advs.202508977 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Advanced Science, online erschienen am 25.07.2025. Verfasst von Runnan Shen und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, 510120, China. Hauptthemen laut MEDLINE: Artificial Intelligence, Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Urine. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, National Science and Technology Major Project, Guangdong Basic and Applied Basic Research Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accurate preoperative diagnosis of muscle invasion (MI) is critical for urothelial carcinoma (UC) management. The aim is to evaluate whether artificial intelligence (AI) model based on urine cytology can accurately detect MIUC and compare its performance with radiologist assessments. UC patients underwent liquid‐based urine cytology from four centers are included for model development/validation. Performance of the precision urine cytology AI solution for MI (PUCAS‐M) is validated across multicenter cohorts and compared to radiologists’ assessments (including CT/MR, MR accounted for 40.7%). Clinical utility is assessed for initial diagnosis, recurrence detection, and neoadjuvant therapy. PUCAS‐M achieves an area under the receiver operation curve (AUROC) of 0.857 (95% CI: 0.820‐0.895) in the whole validation cohort, which is significantly higher ( P ‐value = 0.005) than radiologists (0.773, 95% CI: 0.727–0.818). The integration of radiologists' diagnosis and PUCAS‐M (mPUCAS‐M) significantly increases the sensitivity of radiologists from 63.9% to 83.3% in bladder cancer and from 76.9% to 90.3% in upper‐tract UC. Lastly, in the neoadjuvant therapy subgroups, mPUCAS‐M maintains an improved AUROC (ranging from 0.857‐0.865), whereas radiologist assessments' performance decline. PUCAS‐M provides accurate, non‐invasive MI detection method, particularly valuable for equivocal imaging. Integration with clinical data enhances diagnostic precision, offering a scalable solution for UC management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Artificial IntelligenceUrinary Bladder NeoplasmsCarcinoma, Transitional CellUrineCytodiagnosisHumansMaleFemaleProspective StudiesAgedMiddle AgedNeoplasm InvasivenessAged, 80 and over

Stichwörter der Autor:innen

artificial intelligencemuscle invasiveprospective validationurine cytologyurothelial carcinoma

Autor:innen und Institutionen

  • Department of Urology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, 510120, China.
  • Guangdong Provincial Key Laboratory of Malignant Tumour Epigenetics and Gene Regulation, Guangdong-Hong Kong Joint Laboratory for RNA Medicine, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, 510120,…
  • Guangdong Provincial Clinical Research Centre for Urological Diseases, Guangzhou, 510120, China.
  • CellsVision Medical Technology Services Co., Ltd., Guangzhou, 510260, China.
  • Department of Urology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, 510630, China.
  • Department of Pathology, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, 510120, China.

ORCID-Profile: Shaoxu Wu

Förderung

  • National Natural Science Foundation of China
  • National Science and Technology Major Project
  • Guangdong Basic and Applied Basic Research Foundation
  • Guangzhou Science and Technology Program Project
  • Guangdong Provincial Clinical Research Centre for Urological Diseases
  • Science and Technology Planning Project of Guangdong Province
  • Basic and Applied Basic Research Foundation of Guangdong Province

Zitieren

APA

Shen, R., Jiang, F., Huang, X., Hong, G., Luo, Y., Wan, H., Xie, Y., Zhu, M., Wang, Y., Liu, B., Qin, P., Wang, Y., Wang, H., Yang, H., Lin, Z., Chen, R., Ouyang, N., Huang, J., Lin, T., & Wu, S. (2025). Artificial Intelligence‐Assisted Urine Cytology for Noninvasive Detection of Muscle‐Invasive Urothelial Carcinoma: A Multi‐Center Diagnostic Study with Prospective Validation. Advanced Science, 12(39). https://doi.org/10.1002/advs.202508977

Vancouver

Shen R, Jiang F, Huang X, Hong G, Luo Y, Wan H, et al. Artificial Intelligence‐Assisted Urine Cytology for Noninvasive Detection of Muscle‐Invasive Urothelial Carcinoma: A Multi‐Center Diagnostic Study with Prospective Validation. Advanced Science. 2025;12(39). doi:10.1002/advs.202508977

BibTeX
@article{Shen2025,
  author = {Shen, Runnan and Jiang, Fan and Huang, Xiaowei and Hong, Guibin and Luo, Yun and Wan, Huan and Xie, Ye and Zhu, Mengyi and Wang, Yun and Liu, Bohao and Qin, Ping and Wang, Yahui and Wang, Haoxuan and Yang, Hongkun and Lin, Zhen and Chen, Rui and Ouyang, Nengtai and Huang, Jian and Lin, Tianxin and Wu, Shaoxu},
  title = {Artificial Intelligence‐Assisted Urine Cytology for Noninvasive Detection of Muscle‐Invasive Urothelial Carcinoma: A Multi‐Center Diagnostic Study with Prospective Validation},
  journal = {Advanced Science},
  year = {2025},
  volume = {12},
  number = {39},
  doi = {10.1002/advs.202508977}
}
Kostenlos starten →